ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
123.906,55
-0,32%
S&P 500
5.460,48
-0,41%
US Dollar vs BRL
5,59338
0,00%
Bitcoin
61.525,01
1,04%
Brent Oil
84,85
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Hyperfine Inc (HYPR)

  7. Hyperfine Inc (HYPR) Notícias

HYPR

Hyperfine (HYPR)

Hyperfine Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:HYPR
DataHoraFonteTítuloCódigoCompanhia
25/06/202410:00Business WireClinical Research Using Swoop® System for Alzheimer's Disease Monitoring to be Presented at the 2024 Alzheimer’s Association International ConferenceNASDAQ:HYPRHyperfine Inc
12/06/202417:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HYPRHyperfine Inc
03/06/202417:05Business WireHyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024NASDAQ:HYPRHyperfine Inc
28/05/202410:00Business WireHyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to IndiaNASDAQ:HYPRHyperfine Inc
22/05/202417:05Business WireHyperfine, Inc. to Present at the Jefferies Global Healthcare ConferenceNASDAQ:HYPRHyperfine Inc
22/05/202410:00Business WireHyperfine, Inc. Celebrates ASNR 2024NASDAQ:HYPRHyperfine Inc
16/05/202418:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HYPRHyperfine Inc
14/05/202417:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HYPRHyperfine Inc
13/05/202417:05GlobeNewswire Inc.Hyperfine, Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:HYPRHyperfine Inc
10/05/202410:00Business WireHyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European MarketsNASDAQ:HYPRHyperfine Inc
29/04/202417:05Business WireHyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:HYPRHyperfine Inc
23/04/202410:00Business WireHyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical ConditionsNASDAQ:HYPRHyperfine Inc
17/04/202410:00Business WireLeading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR StudyNASDAQ:HYPRHyperfine Inc
21/03/202417:05GlobeNewswire Inc.Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:HYPRHyperfine Inc
21/03/202408:26IH Market NewsU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor DeclinesNASDAQ:HYPRHyperfine Inc
12/03/202410:00Business WireHyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess RoyalNASDAQ:HYPRHyperfine Inc
07/03/202418:30Business WireHyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024NASDAQ:HYPRHyperfine Inc
28/02/202418:30Business WireHyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare ConferenceNASDAQ:HYPRHyperfine Inc
21/02/202411:00Business WireHyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional AthletesNASDAQ:HYPRHyperfine Inc
01/02/202410:00Business WireHyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational StudyNASDAQ:HYPRHyperfine Inc
09/01/202411:00Business WireHyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of UseNASDAQ:HYPRHyperfine Inc
24/11/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HYPRHyperfine Inc
20/11/202320:20Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:HYPRHyperfine Inc
20/11/202311:00Business WireHyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023NASDAQ:HYPRHyperfine Inc
16/11/202311:00Business WireHyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:HYPRHyperfine Inc
09/11/202318:43Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:HYPRHyperfine Inc
09/11/202318:05GlobeNewswire Inc.Hyperfine, Inc. Reports Third Quarter 2023 Financial ResultsNASDAQ:HYPRHyperfine Inc
02/11/202310:15Business WireObservational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO PatientsNASDAQ:HYPRHyperfine Inc
19/10/202317:05Business WireHyperfine, Inc. to Announce Third Quarter Financial Results on November 9, 2023NASDAQ:HYPRHyperfine Inc
10/10/202317:05Business WireHyperfine, Inc. Announces Promotions of Two Key Clinical Affairs ExecutivesNASDAQ:HYPRHyperfine Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:HYPR

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
GOLL4
GOL PN
BOV
PETR4
PETROBRAS PN
BOV
IDIV
Dividend
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados